Pharmacology Quiz: Adrenergic Agonists
20 questions · exam conditions
0:00
Adrenergic AgonistsQuestion 1 of 20

A patient in the intensive care unit for septic shock develops oliguria despite adequate fluid resuscitation. A low-dose infusion of an adrenergic agonist is initiated specifically to improve renal perfusion by causing selective vasodilation of the renal arteries. This targeted effect is mediated primarily by agonist activity at which receptor?

β1-receptors in the juxtaglomerular apparatus.
α1-receptors in the efferent arterioles.
β2-receptors in the renal vasculature.
Dopamine D1 receptors in the renal vasculature.
← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Adrenergic Agonists

Practice Adrenergic Agonists in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Adrenergic Agonists, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient in the intensive care unit for septic shock develops oliguria despite adequate fluid resuscitation. A low-dose infusion of an adrenergic agonist is initiated specifically to improve renal perfusion by causing selective vasodilation of the renal arteries. This targeted effect is mediated primarily by agonist activity at which receptor?

  1. β1-receptors in the juxtaglomerular apparatus.
  2. α1-receptors in the efferent arterioles.
  3. β2-receptors in the renal vasculature.
  4. Dopamine D1 receptors in the renal vasculature. (correct answer)
Explanation: At low doses, dopamine is unique among catecholamines for its ability to selectively activate D1 receptors, which are prominent in the renal, mesenteric, and coronary vascular beds. Activation of D1 receptors in the kidney leads to vasodilation, increasing renal blood flow and promoting natriuresis. This is the principle behind the use of 'renal-dose' dopamine, though its clinical utility is debated. β2 agonism can cause vasodilation, but it is not the primary mechanism for this specific indication. α1 agonism would cause vasoconstriction, and β1 agonism would primarily affect renin release.

Question 2

In an experimental preparation, the sympathetic nerve terminals innervating a rabbit heart are depleted of their endogenous catecholamines by pretreatment with reserpine. The subsequent administration of which of the following drugs would result in a significantly blunted chronotropic (heart rate) response compared to an untreated animal?

  1. Norepinephrine
  2. Amphetamine (correct answer)
  3. Isoproterenol
  4. Dobutamine
Explanation: Amphetamine is an indirect-acting sympathomimetic amine. Its primary mechanism of action is to promote the release of endogenous norepinephrine from presynaptic nerve terminals. Reserpine depletes these terminals of norepinephrine. Therefore, in a reserpine-pretreated animal, amphetamine has no norepinephrine to release and its effects will be severely blunted. In contrast, norepinephrine, isoproterenol, and dobutamine are all direct-acting agonists that stimulate adrenergic receptors directly and would still be effective in this preparation.

Question 3

A patient uses an over-the-counter oxymetazoline nasal spray for 10 consecutive days to manage allergic rhinitis. They report that while the spray was initially effective, their nasal congestion is now worse than before, even immediately after use. This phenomenon of rhinitis medicamentosa is best explained by which of the following cellular mechanisms?

  1. Depletion of presynaptic norepinephrine stores in the nasal mucosa.
  2. Competitive antagonism at α1-receptors by a slowly accumulating drug metabolite.
  3. Downregulation and internalization of postsynaptic α1-adrenergic receptors. (correct answer)
  4. Formation of drug-specific IgE antibodies leading to localized inflammation.
Explanation: Oxymetazoline is a direct-acting α1-adrenergic agonist. Prolonged or excessive stimulation of these receptors leads to a compensatory downregulation and internalization of the receptors, a form of homologous desensitization. This reduces the tissue's responsiveness to the drug, causing tachyphylaxis and rebound congestion. Depletion of norepinephrine stores is the mechanism of tachyphylaxis for indirect-acting agonists like ephedrine or amphetamine. The other options describe incorrect or less likely mechanisms.

Question 4

A healthy volunteer is administered a continuous intravenous infusion of phenylephrine. Assuming a normal and intact baroreceptor reflex, what are the expected net effects on mean arterial pressure (MAP) and heart rate (HR)?

  1. Increased MAP and increased HR.
  2. Increased MAP and decreased HR. (correct answer)
  3. Decreased MAP and increased HR.
  4. Decreased MAP and decreased HR.
Explanation: Phenylephrine is a selective α1-adrenergic agonist. Its primary effect is potent vasoconstriction, leading to a significant increase in systemic vascular resistance and, consequently, mean arterial pressure (MAP). This sharp rise in MAP is sensed by baroreceptors in the carotid sinus and aortic arch. The baroreceptor reflex is then activated, leading to increased parasympathetic (vagal) outflow to the heart and decreased sympathetic tone, which results in a compensatory decrease in heart rate (reflex bradycardia).

Question 5

A patient uses an over-the-counter oxymetazoline nasal spray for 10 consecutive days to manage allergic rhinitis. They report that while the spray was initially effective, their nasal congestion is now worse than before, even immediately after use. This phenomenon of rhinitis medicamentosa is best explained by which of the following cellular mechanisms?

  1. Depletion of presynaptic norepinephrine stores in the nasal mucosa.
  2. Competitive antagonism at α1-receptors by a slowly accumulating drug metabolite.
  3. Downregulation and internalization of postsynaptic α1-adrenergic receptors. (correct answer)
  4. Formation of drug-specific IgE antibodies leading to localized inflammation.
Explanation: Oxymetazoline is a direct-acting α1-adrenergic agonist. Prolonged or excessive stimulation of these receptors leads to a compensatory downregulation and internalization of the receptors, a form of homologous desensitization. This reduces the tissue's responsiveness to the drug, causing tachyphylaxis and rebound congestion. Depletion of norepinephrine stores is the mechanism of tachyphylaxis for indirect-acting agonists like ephedrine or amphetamine. The other options describe incorrect or less likely mechanisms.

Question 6

A patient being treated with oral terbutaline to prevent preterm labor complains of a fine, bothersome tremor in her hands. This common side effect is a direct result of the drug's agonist activity on which of the following?

  1. β1-receptors in the sinoatrial node
  2. β2-receptors in skeletal muscle fibers (correct answer)
  3. α1-receptors in the basal ganglia
  4. Muscarinic receptors at the neuromuscular junction
Explanation: Terbutaline is a β2-adrenergic agonist. While its therapeutic effect in preterm labor is due to β2-receptor stimulation in the uterine smooth muscle (causing relaxation), the drug also stimulates β2-receptors located on skeletal muscle. This activation enhances the physiological tremor, leading to the fine tremor commonly seen as a side effect. Stimulation of β1-receptors would cause tachycardia. The other options describe incorrect receptor targets or locations for this effect.

Question 7

To facilitate a funduscopic examination, an ophthalmologist administers eye drops that produce effective mydriasis (pupil dilation) with minimal cycloplegia (paralysis of accommodation). This pharmacological profile is characteristic of a drug that selectively stimulates which of the following receptors?

  1. Muscarinic M3 receptors on the pupillary constrictor muscle.
  2. β2-adrenergic receptors on the ciliary epithelium.
  3. α1-adrenergic receptors on the pupillary dilator muscle. (correct answer)
  4. Nicotinic Nn receptors in the ciliary ganglion.
Explanation: Mydriasis without significant cycloplegia is achieved by stimulating the α1-adrenergic receptors on the radial (pupillary dilator) muscle of the iris. This contracts the muscle and dilates the pupil. Phenylephrine is a classic example of such a drug. In contrast, antimuscarinic drugs (which block M3 receptors) cause mydriasis by relaxing the pupillary constrictor muscle but also cause cycloplegia by relaxing the ciliary muscle. β2-receptors are primarily involved in aqueous humor production, not pupillary control.

Question 8

A 58-year-old male with a history of type 2 diabetes and chronic obstructive pulmonary disease (COPD) presents with an acute exacerbation. He is treated with nebulized albuterol. One hour later, a point-of-care blood glucose measurement is significantly elevated. This metabolic side effect is primarily mediated by the stimulation of which adrenergic receptor?

  1. α2-receptors in the pancreatic islets, which inhibits insulin secretion.
  2. β1-receptors in the pancreas, which stimulates glucagon secretion.
  3. β2-receptors in the liver and skeletal muscle, which promotes glycogenolysis. (correct answer)
  4. α1-receptors in the liver, which directly stimulates gluconeogenesis.
Explanation: Albuterol is a selective β2-agonist. Stimulation of β2-adrenergic receptors in the liver and skeletal muscle activates adenylyl cyclase, increases cAMP, and promotes glycogenolysis (breakdown of glycogen to glucose), leading to hyperglycemia. While α2-agonism can inhibit insulin secretion and β1-agonism can stimulate glucagon release, the primary mechanism for hyperglycemia from a β2-agonist is increased glucose production via glycogenolysis.

Question 9

In the management of distributive shock, norepinephrine is often chosen over epinephrine as the first-line vasopressor. A key pharmacological reason for this preference is that, at typical therapeutic doses, norepinephrine:

  1. is a more potent β1-agonist, providing superior inotropic support.
  2. has significantly less β2-agonist activity, resulting in more reliable vasoconstriction. (correct answer)
  3. causes less reflex bradycardia due to its weaker effects on baroreceptors.
  4. lacks α1-agonist activity, thereby preserving visceral organ perfusion.
Explanation: Both norepinephrine and epinephrine are potent α1 and β1 agonists. However, epinephrine also has significant β2-agonist activity, which causes vasodilation in certain vascular beds (like skeletal muscle). This can counteract its α1-mediated vasoconstriction and can sometimes lower diastolic pressure. Norepinephrine has very weak β2 activity. Therefore, it produces more consistent and powerful vasoconstriction, making it a more reliable agent for raising mean arterial pressure in distributive shock. The β2 activity of epinephrine can also increase lactate levels, which can complicate clinical assessment.

Question 10

The administration of an adrenergic agonist causes contraction of vascular smooth muscle. The intracellular signaling cascade responsible for this effect involves G-protein-mediated activation of phospholipase C, which in turn generates the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG). This entire pathway is initiated by the binding of the agonist to which receptor subtype?

  1. α1-adrenergic (correct answer)
  2. α2-adrenergic
  3. β1-adrenergic
  4. β2-adrenergic
Explanation: The α1-adrenergic receptor is coupled to the Gq protein. Activation of Gq stimulates phospholipase C (PLC). PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the release of Ca2+ from intracellular stores, and DAG activates protein kinase C, both of which contribute to smooth muscle contraction. β receptors are Gs-coupled (activating adenylyl cyclase), and α2 receptors are Gi-coupled (inhibiting adenylyl cyclase).

Question 11

In the management of distributive shock, norepinephrine is often chosen over epinephrine as the first-line vasopressor. A key pharmacological reason for this preference is that, at typical therapeutic doses, norepinephrine:

  1. is a more potent β1-agonist, providing superior inotropic support.
  2. has significantly less β2-agonist activity, resulting in more reliable vasoconstriction. (correct answer)
  3. causes less reflex bradycardia due to its weaker effects on baroreceptors.
  4. lacks α1-agonist activity, thereby preserving visceral organ perfusion.
Explanation: Both norepinephrine and epinephrine are potent α1 and β1 agonists. However, epinephrine also has significant β2-agonist activity, which causes vasodilation in certain vascular beds (like skeletal muscle). This can counteract its α1-mediated vasoconstriction and can sometimes lower diastolic pressure. Norepinephrine has very weak β2 activity. Therefore, it produces more consistent and powerful vasoconstriction, making it a more reliable agent for raising mean arterial pressure in distributive shock. The β2 activity of epinephrine can also increase lactate levels, which can complicate clinical assessment.

Question 12

A 9-year-old child is prescribed extended-release guanfacine for attention-deficit/hyperactivity disorder (ADHD). The medication is found to improve working memory and reduce distractibility. This therapeutic effect is primarily attributed to the stimulation of which receptors in the prefrontal cortex?

  1. Dopamine D1 receptors, which enhance cortical signaling.
  2. Postsynaptic α2A-adrenergic receptors, which strengthen network connectivity. (correct answer)
  3. β1-adrenergic receptors, which increase neuronal firing rates.
  4. Serotonin 5-HT2C receptors, which modulate dopaminergic tone.
Explanation: Guanfacine is a selective α2A-adrenergic agonist. In the context of ADHD, its therapeutic effects are not due to the antihypertensive mechanism in the brainstem, but rather its action on postsynaptic α2A-receptors in the prefrontal cortex (PFC). Stimulation of these receptors is thought to strengthen synaptic connections and improve the signal-to-noise ratio of PFC neuronal networks, which enhances executive functions like working memory and attention regulation. While dopamine is also crucial for PFC function, guanfacine's primary target is the α2A-receptor.

Question 13

A patient presents with anaphylactic shock, exhibiting severe hypotension and bronchoconstriction. Epinephrine is the drug of choice. Its superiority over a pure α-agonist like phenylephrine in this setting is primarily due to epinephrine's potent agonist activity at which receptor?

  1. α1-receptors
  2. β1-receptors
  3. D1-receptors
  4. β2-receptors (correct answer)
Explanation: When you encounter anaphylactic shock questions, think about the dual pathophysiology: severe vasodilation causing hypotension AND bronchoconstriction causing respiratory distress. The ideal treatment must address both problems simultaneously. Epinephrine's superiority over pure α-agonists like phenylephrine lies in its ability to activate β2-receptors. β2-receptor stimulation causes powerful bronchodilation by relaxing smooth muscle in the airways, directly counteracting the life-threatening bronchoconstriction seen in anaphylaxis. While phenylephrine can address hypotension through α1-mediated vasoconstriction, it cannot reverse the airway obstruction that makes anaphylaxis so deadly. Let's examine why the other options fall short: (A) α1-receptors cause vasoconstriction and help with hypotension, but phenylephrine is actually a potent α1-agonist, so this doesn't explain epinephrine's superiority. (B) β1-receptors provide positive inotropic and chronotropic effects that help cardiac output, but this alone wouldn't make epinephrine superior to phenylephrine for treating hypotension. (C) D1-receptors are dopamine receptors involved in renal vasodilation and aren't relevant to epinephrine's mechanism in anaphylaxis. The correct answer is (D) β2-receptors because bronchodilation is the unique advantage epinephrine provides over pure α-agonists. Study tip: Remember "β2 = breathing" - β2-receptors are your go-to for bronchodilation. In anaphylaxis questions, always consider that successful treatment requires addressing both cardiovascular collapse AND airway obstruction, making epinephrine's dual α/β activity essential.

Question 14

A patient with poorly controlled asthma frequently uses their albuterol inhaler. Over time, they experience a diminished bronchodilator response to the drug. The most likely molecular mechanism underlying this acquired tolerance involves which of the following processes?

  1. Increased hepatic metabolism of albuterol via cytochrome P450 enzymes.
  2. Competitive inhibition of the β2-receptor by an inactive metabolite.
  3. Upregulation of phosphodiesterase activity within bronchial smooth muscle cells.
  4. Phosphorylation of the intracellular domain of the β2-receptor, promoting its uncoupling from Gs protein. (correct answer)
Explanation: This phenomenon is known as tachyphylaxis or desensitization. With repeated or prolonged exposure to an agonist like albuterol, the β2-adrenergic receptor becomes phosphorylated by kinases such as β-adrenergic receptor kinase (BARK) or protein kinase A. This phosphorylation promotes the binding of a protein called β-arrestin to the receptor, which sterically hinders its interaction with its Gs protein, effectively uncoupling it from the downstream signaling pathway (adenylyl cyclase/cAMP). This leads to a diminished cellular and clinical response.

Question 15

A patient with a history of hypertension controlled with propranolol is brought to the emergency department for an anaphylactic reaction to a bee sting. They are given a standard dose of intramuscular epinephrine. Which of the following hemodynamic responses is most likely to occur in this patient?

  1. Exaggerated hypotension due to unopposed β2-mediated vasodilation.
  2. A marked increase in blood pressure accompanied by reflex bradycardia. (correct answer)
  3. Pronounced tachycardia with only a modest increase in blood pressure.
  4. A blunted response with minimal change in blood pressure or heart rate.
Explanation: Propranolol is a non-selective β-blocker, blocking both β1 and β2 receptors. When epinephrine is administered, its β-adrenergic effects are blocked. However, its α1-adrenergic effects (vasoconstriction) are not blocked and are therefore 'unopposed'. This leads to a severe increase in peripheral resistance and blood pressure. The β1-mediated tachycardia is blocked, and the profound hypertension triggers a strong baroreceptor reflex, resulting in significant reflex bradycardia. This is a classic and dangerous drug interaction.

Question 16

A patient in cardiogenic shock is treated with a continuous intravenous infusion of an adrenergic agonist. Hemodynamic monitoring shows a significant increase in cardiac output and heart rate, accompanied by a decrease in systemic vascular resistance. Which of the following agents was most likely administered?

  1. Norepinephrine
  2. Phenylephrine
  3. Isoproterenol (correct answer)
  4. Dobutamine
Explanation: The observed effects are a marked increase in heart rate and cardiac output (β1 effect) and a decrease in systemic vascular resistance (β2 effect). Isoproterenol is a non-selective β-agonist with potent activity at both β1 and β2 receptors, matching this profile perfectly. Norepinephrine has strong α1 and β1 activity, which would increase SVR. Phenylephrine is a pure α1-agonist, which would increase SVR and cause reflex bradycardia. Dobutamine is primarily a β1-agonist with weaker β2 activity, and it would be less likely to cause a significant drop in SVR compared to isoproterenol.

Question 17

A 58-year-old male with a history of type 2 diabetes and chronic obstructive pulmonary disease (COPD) presents with an acute exacerbation. He is treated with nebulized albuterol. One hour later, a point-of-care blood glucose measurement is significantly elevated. This metabolic side effect is primarily mediated by the stimulation of which adrenergic receptor?

  1. α2-receptors in the pancreatic islets, which inhibits insulin secretion.
  2. β1-receptors in the pancreas, which stimulates glucagon secretion.
  3. β2-receptors in the liver and skeletal muscle, which promotes glycogenolysis. (correct answer)
  4. α1-receptors in the liver, which directly stimulates gluconeogenesis.
Explanation: Albuterol is a selective β2-agonist. Stimulation of β2-adrenergic receptors in the liver and skeletal muscle activates adenylyl cyclase, increases cAMP, and promotes glycogenolysis (breakdown of glycogen to glucose), leading to hyperglycemia. While α2-agonism can inhibit insulin secretion and β1-agonism can stimulate glucagon release, the primary mechanism for hyperglycemia from a β2-agonist is increased glucose production via glycogenolysis.

Question 18

A healthy volunteer is administered a continuous intravenous infusion of phenylephrine. Assuming a normal and intact baroreceptor reflex, what are the expected net effects on mean arterial pressure (MAP) and heart rate (HR)?

  1. Increased MAP and increased HR.
  2. Increased MAP and decreased HR. (correct answer)
  3. Decreased MAP and increased HR.
  4. Decreased MAP and decreased HR.
Explanation: Phenylephrine is a selective α1-adrenergic agonist. Its primary effect is potent vasoconstriction, leading to a significant increase in systemic vascular resistance and, consequently, mean arterial pressure (MAP). This sharp rise in MAP is sensed by baroreceptors in the carotid sinus and aortic arch. The baroreceptor reflex is then activated, leading to increased parasympathetic (vagal) outflow to the heart and decreased sympathetic tone, which results in a compensatory decrease in heart rate (reflex bradycardia).

Question 19

A patient taking an over-the-counter oral decongestant containing pseudoephedrine presents with palpitations and a blood pressure of 160/95 mmHg. The cardiovascular effects of this agent are best explained by which combination of mechanisms?

  1. Selective agonism at postsynaptic β2-receptors and presynaptic α2-receptors.
  2. Inhibition of monoamine oxidase and catechol-O-methyltransferase.
  3. Direct stimulation of adrenergic receptors and promotion of endogenous norepinephrine release. (correct answer)
  4. Blockade of norepinephrine reuptake transporters exclusively.
Explanation: Pseudoephedrine is a mixed-acting adrenergic agonist. This means it exerts its effects through two primary mechanisms: 1) directly stimulating α- and β-adrenergic receptors, and 2) indirectly acting by causing the release of endogenous norepinephrine from presynaptic nerve terminals. This dual action leads to its cardiovascular side effects, including vasoconstriction (hypertension) and increased heart rate/contractility (palpitations).

Question 20

A 65-year-old woman is prescribed mirabegron for symptoms of overactive bladder. This medication alleviates urinary urgency and frequency by promoting relaxation of the detrusor muscle. This therapeutic effect is mediated by agonism at which of the following receptors?

  1. β3-adrenergic receptors (correct answer)
  2. α1-adrenergic receptors
  3. Muscarinic M3 receptors
  4. β2-adrenergic receptors
Explanation: Mirabegron is a selective β3-adrenergic receptor agonist. The β3-receptors are highly expressed on the detrusor muscle of the urinary bladder. Stimulation of these receptors leads to smooth muscle relaxation, which increases bladder capacity and reduces the symptoms of overactive bladder. Agonism at α1-receptors would contract the bladder neck, while antagonism of M3 receptors is another strategy to relax the detrusor muscle.